Amniocentesis Needle Market Size, Share, Growth – By Product Type, By Procedure, By End Use, Global Forecast, 2024 – 2032

Report ID: GMI8186
   |
Published Date: November 2024
 | 
Report Format: PDF

Download Free PDF

Amniocentesis Needle Market Size

The global amniocentesis needle market size was valued at around USD 176.7 million in 2023 and is estimated to grow at 4.9% CAGR from 2024 to 2032. The usage of an amniocentesis needle permits the performance of amniocentesis, which is the process of taking amniotic fluid from the membrane that covers the developing fetus during pregnancy.
 

Amniocentesis Needle Market

The increase in the prevalence of chronic disease such as diabetes, hypertension, autoimmune diseases, and some genetic disorders among pregnant women tends to positively benefit the demand and supply of amniocentesis needles. It has been found, as modern research shows, that over 14.7% global prevalence of gestational diabetes mellitus was found in 2022. Additionally, above the age of 35, women are likely to be advised to undergo amniocentesis tests to check the fetal chromosomes, therefore increasing the demand for amniocentesis needles to be used in clinics.
 

Moreover, the increase in the prevalence of congenital anomalies and the rising rates of amniocentesis procedures performed should also contribute positively to the revenue obtained in the market. The modification of design and technology as well as the use of the amniocentesis needles makes them more effective and safer. All these considerations together cause an increase in the amount of amniocentesis procedures performed in a bid to aid early detection and treatment of fetal health problems, leading to continuous growth of the market.
 

Amniocentesis Needle Market Trends

The amniocentesis needle is undergoing continuous advancement, incorporating technological changes aimed at accuracy, safety, and efficiency.
 

  • The procedure for Amniocentesis has benefited from technological advancements that led to the development of ultra-thin precision needles. These specially engineered needles have a fine diameter and are steerable, thereby increasing patient comfort and reducing potential problems like infection and bleeding. The new design also allows greater control over sample collection from the amniotic sac, thereby increasing accuracy.
     
  • The focus on miniaturization is one of the most significant advancements in amniocentesis technology. The smaller diameter of the needles increases tissue elasticity and reduces the likelihood of fetal injury. These vessels also have steering capabilities, allowing for better control and accurate positioning during the procedure.
     
  • The introduction of the Amniocentesis hypodermic needle with super sharp tips by Argon Medical Devices Inc. is a landmark advancement in technology. The slices at the tip of the needle enhance penetration at the dull cortex of the fetus and the ergonomically shaped handle increases tactile comfort. Other safety features include retractable needles and automated systems that significantly reduce needle stick injuries for health care workers and improve the safety of patients.
     
  • Innovative technologies certification provides new means to monitor performance, lowering complication risk and enhancing health’s safety profile. Health care experts are thereby encouraged to conduct more amniocentesis procedures which automatic needles in turn increase the demand for these innovative needles.
     

Amniocentesis Needle Market Analysis

Amniocentesis Needle Market, By Product Type, 2021 – 2032 (USD Million)

Segmenting the market by product type reveals three categories: 100 to 150 mm, smaller than 100 mm, and larger than 150 mm. In 2023, the 100 to 150 mm segment led the market, generating a revenue of USD 92.2 million, and is projected to witness a robust CAGR during the forecast period.
 

  • This needle length is most suitable for reaching the amniotic sac which is usually located 8 to 12 cm beneath the abdominal wall in the second trimester.
     
  • Needles of this dimension are capable of performing accurate amniocentesis, effortlessly penetrating deep enough to aspirate the desired quantity of amniotic fluid.
     
  • Additionally, several advanced needles of this type are designed with a syringe stopper and a female luer lock for aspiration which improve the ease and safety of the procedures.
     
  • Such advances aimed to enhance the safety of the procedures but also reduce the potential damage to the fetus as well as the surrounding tissue making them more acceptable to the medical profession.
     
  • This trend towards the use of longer needles is based on the ability to reach the amniotic sac without risking damage to the fetus.
     
  • These needles cater to females with normal body mass index (BMI) which according to the National Library of Medicine, 52.6% of pregnant women belong to, thus assuring a high adoption among this population. This combination of safety and broad population coverage is the reason for the growth of the market.
     
Amniocentesis Needle Market, By Procedure (2023)

Segmented by procedure, the amniocentesis needle market includes amniocentesis procedures, amnioreduction procedures, fetal blood transfusions, amnioinfusion procedures, and cordocentesis procedures. In 2023, the amniocentesis procedures segment commanded a notable 33.1% share of the market and is poised for robust growth.
 

  • Amniocentesis is a procedure that remains indispensable as a diagnostic method for delineating genetic disorders which include - Down syndrome, Trisomy 18, and neural tube defects.
    Amniocentesis achieves this through chromosomal analysis and providing further insights into the fetus’s genetic profile, which provides the definitive diagnosis with less probabilities of uncertainties.
     
  • Amniocentesis boosts the remarkable accuracy scale for Down syndrome. For instance, the National Health Services have identified that 98 to 99 of every 100 women who go through the procedure are certain to receive definitive results, emphasizing its wide use. Similarly, it is also effective for open neural tube defects, which include spina bifida, where success rates of 98% to 99% are achieved.
     
  • Such precision enables the parents to make edits decisions over their pregnancy. Genetic disorders are detrimental and the earlier they are detected the more valuable the treatment improves the eventual outcome.
     
  • Therefore, all these aspects are highly likely to enhance the overall health of the consumers, resulting in an increment in volume of this segment of market.
     

Segmented by end use, the amniocentesis needle market encompasses hospitals, diagnostic centers, clinics, and other users. In 2023, hospitals led the market with a commanding 50.7% share and are projected for notable expansion.
 

  • Hospitals have the requisite basic structure with the necessary human resources and well-equipped advanced devices, which makes sure that the procedures are performed with the highest degree of safety and efficacy witnessing it as a primary preference for the patients.
     
  • The increasing number of hospitals serves as a motivating factor for the growth of the market. For instance, the number of hospitals managed in the U.S was around 6,093 in 2023 and this expects to boast the adoption of the use of amniocentesis procedures.
     
  • The hospital comprises of departments such as obstetrics and gynecology, which means hospitals have the infrastructure to make safe amniocentesis needles ensuring safe prenatal amniocentesis procedures. In addition, their ability to buy and store amniocentesis needles puts them in an even stronger position.
     
  • Hospitals get involved in R&D of prenatal and diagnosis care so that they always seem to be ahead of the competition. They tend to be among the first to adopt advanced amniocentesis technology and needles, which strengthens their market position.
     
U.S. Amniocentesis Needle Market, 2021 – 2032 (USD Million)

In 2023, the U.S. led the North American amniocentesis needle market, generating a revenue of USD 62.6 million.
 

  • The higher prevalence of congenital disorders with growing need for amniocentesis which enables early diagnosis during pregnancy has witnessed U.S. leadership in the North American market.
     
  • For instance, the Children’s Heart Foundation indicates that approximately 40,000 infants in U.S. get born with some form of congenital heart defects (CHDs) every year, which makes roughly 1 kid every 15 minutes. Furthermore, with 2-3 million people in the U.S. population living with CHDs, the ability to detect them early puts even more emphasis on the need for amniocentesis level.
     
  • Moreover, the U.S. features a well-developed healthcare and medical infrastructure along with specialized dental prenatal services. This system not only helps, but also encourages the adoption of procedures like amniocentesis, which is quite beneficial. Considering the increased occurrence of congenital conditions and the superior amniocentesis services, the U.S. market for amniocentesis needles is anticipated to rise significantly in coming years.
     

The UK is set to see a robust expansion in its amniocentesis needle market from 2024 to 2032.
 

  • The UK growth is asserted to the growing government initiatives such as the National Health Service (NHS) enables access to every pregnant woman thereby increasing public availability of prenatal screening tests such amniocentesis. This comprehensive coverage of the NHS facilitated consistent demand for high quality amniocentesis needles across the country.
     
  • The UK has numerous advanced research centers and institutions dedicated to the improvement of prenatal care and medical devices.
     
  • The joint efforts of research institutions and manufacturers of medical devices contribute towards more efficient and safer designs and usages of needles, including those used for amniocentesis.

Japan's amniocentesis needle market is set for lucrative growth of 5% from 2024 to 2032.
 

  • Japan’s significant investment on healthcare R&D and the and the synergetic efforts of academia, the government and the medical device manufacturers has strengthened the country’s position in the market.
     
  • This investment tends to escalate the research efforts featuring advancement such as adjustable stoppers as well as increased needle accuracy, are important in achieving reliable patient results.

Saudi Arabia's amniocentesis needle market is on the brink of substantial growth from 2024 to 2032.
 

  • The growing government support to improve needle amniocentesis services have greatly complemented Saudi Arabia’s healthcare vision 2030 strategy which advocates better access to sophisticated medical services and technology. This increase in availability of amniocentesis services increases the need for high quality needles.
     
  • In addition, as recurrent pregnancy loss is gaining concern in Saudi Arabia, an increasing number of pregnant women when needing to perform early diagnosis for genetic disorders, are opting towards amniocentesis procedures. Advances from both ends, patients and healthcare professionals, are widening the market for precision needles.
     

Amniocentesis Needle Market Share

The market is characterized by high competition that stems from a mix of large multinational businesses and small to medium-sized companies vying for the market share. A key marketing strategy involves the consistent product launches focusing on innovative needle designs improved safety features, such as, adjustable depth stoppers and precision- guided technologies.
 

Industry leaders significantly wielding for continuous innovation due to massive resources devoted to R&D tend to dominate the industry. In addition, strategic approaches such as mergers and acquisitions, and joint ventures further solidified the company's position in the market. Moreover, the increasing emphasis on patient safety along with a preference for minimally invasive techniques using the premium materials continued to shape the market competitiveness. 
 

Amniocentesis Needle Market Companies

Some of the eminent market participants operating in the amniocentesis needle industry include:

  • Becton, Dickinson and Company
  • Biopsybell
  • Cardinal Health
  • Eurosurgical
  • Laboratoire CCD
  • M.D.L
  • McKesson Corporation
  • Medax
  • Medline Industries
  • Moller Medical
  • RI.MOS
  • Roko
  • Suzhou Leapmed Healthcare Corporation
  • The Cooper Companies
  • Vigeo
     

USPs of the company

  • Robust R&D investment driving technological advancement and innovation.
     
  • Focus on regulatory compliance ensuring premium product reliability.
     
  • Competitive pricing strategy aligned with market affordability and standards.
     

Amniocentesis Needle Industry News:

  • In May 2023, Cardinal Health announced plans to open a new distribution center in the Greater Toronto Area (GTA), expanding its distribution footprint to nine strategic locations to better meet the medical and surgical product, including accessories and needles, demands of the Canadian healthcare system. Thus, it expanded the sales of the company.
     
  • In March 2021, Becton, Dickinson and Company introduced the BD Chorionic Villus Sampling (CVS) System, featuring an innovative ergonomic handle designed to minimize hand fatigue and improve accuracy during amniocentesis procedures. This increased the sales of the needle. Thus, it augmented the market expansion of the company.
     

The amniocentesis needle market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Market, By Product Type

  • 100 to 150 mm
  • Smaller than 100 mm
  • Larger than 150 mm          

Market, By Procedure

  • Amniocentesis procedures  
  • Amnioreduction procedures
  • Fetal blood transfusions
  • Amnioinfusion procedures
  • Cordocentesis procedures

Market, By End Use

  • Hospitals
  • Diagnostic centers   
  • Clinics
  • Other end users

The above information is provided for the following regions and countries:

  • North America 
    • U.S.
    • Canada
  • Europe 
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific 
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America 
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa 
    • South Africa
    • Saudi Arabia
    • UAE

 

Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
How much was the U.S. amniocentesis needle industry worth?
The U.S. market was valued at USD 62.6 million in 2023, led by a higher prevalence of congenital disorders.
Who are the major players in the amniocentesis needle market?
How big is the amniocentesis needle market?
What was the market share of the amniocentesis procedures segment in 2023?
Amniocentesis Needle Market Scope
  • Amniocentesis Needle Market Size
  • Amniocentesis Needle Market Trends
  • Amniocentesis Needle Market Analysis
  • Amniocentesis Needle Market Share
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2023

    Companies covered: 15

    Tables & Figures: 100

    Countries covered: 18

    Pages: 135

    Download Free PDF

    Top